A detailed history of Brandywine Global Investment Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 804,265 shares of MRK stock, worth $80.5 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
804,265
Previous 83,036 868.57%
Holding current value
$80.5 Million
Previous $10.3 Million 788.53%
% of portfolio
0.64%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $80.2 Million - $93 Million
721,229 Added 868.57%
804,265 $91.3 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $463,135 - $497,403
3,741 Added 4.72%
83,036 $10.3 Million
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $128 Million - $149 Million
-1,130,363 Reduced 93.44%
79,295 $10.5 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $5.37 Million - $5.85 Million
-53,635 Reduced 4.25%
1,209,658 $132 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $7.38 Million - $8.2 Million
-71,725 Reduced 5.37%
1,263,293 $130 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $13.4 Million - $14.6 Million
-123,600 Reduced 8.47%
1,335,018 $154 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $9.71 Million - $10.8 Million
-94,304 Reduced 6.07%
1,458,618 $155 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $3.97 Million - $5.09 Million
-45,387 Reduced 2.84%
1,552,922 $172 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $16.6 Million - $18.7 Million
-196,775 Reduced 10.96%
1,598,309 $138 Million
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $9.59 Million - $10.9 Million
-114,837 Reduced 6.01%
1,795,084 $164 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $6.49 Million - $7.27 Million
-88,226 Reduced 4.42%
1,909,921 $157 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $142 Million - $178 Million
1,962,547 Added 5512.77%
1,998,147 $153 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $32,399 - $35,631
-452 Reduced 1.25%
35,600 $2.67 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $236,522 - $261,618
-3,364 Reduced 8.53%
36,052 $2.8 Million
Q1 2021

May 13, 2021

SELL
$68.86 - $81.11 $147 Million - $173 Million
-2,127,572 Reduced 98.18%
39,416 $3.04 Million
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $3.78 Million - $4.2 Million
-52,735 Reduced 2.38%
2,166,988 $177 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $4.54 Million - $5.15 Million
-62,076 Reduced 2.72%
2,219,723 $184 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $3.67 Million - $4.18 Million
52,161 Added 2.34%
2,281,799 $176 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $1.75 Million - $2.43 Million
-27,619 Reduced 1.22%
2,229,638 $172 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $27.4 Million - $30.9 Million
352,722 Added 18.52%
2,257,257 $208 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $11.5 Million - $12.6 Million
-151,599 Reduced 7.37%
1,904,535 $160 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $11.2 Million - $13.1 Million
160,594 Added 8.47%
2,056,134 $172 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $3.36 Million - $3.83 Million
-48,264 Reduced 2.48%
1,895,540 $158 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $1.09 Million - $1.26 Million
-16,639 Reduced 0.85%
1,943,804 $149 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $3.64 Million - $4.28 Million
-63,085 Reduced 3.12%
1,960,443 $139 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $103 Million - $121 Million
2,023,528 New
2,023,528 $123 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $124 Million - $148 Million
-2,394,958 Closed
0 $0
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $4.97 Million - $5.35 Million
-84,700 Reduced 3.42%
2,394,958 $153 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,479,658
2,479,658 $159 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.